Former Bio-Rad EVP & CFO brings deep sector, financial, and governance experience to support Araceli’s next phase of growth PORTLAND, Ore. — Araceli Biosciences today announced the appointment of Christine A. Tsingos to its Board of Directors, adding a seasoned public company executive with extensive experience in financial leadership, governance, and strategic growth. Tsingos brings more than 30 years […]
New program matches top researchers with expert service providers trained to offer a comprehensive suite of Shasta® single-cell and bulk RNA-seq NGS solutions SAN JOSE, Calif. — Takara Bio USA, Inc. (“Takara Bio USA”), a wholly owned subsidiary of Takara Bio Inc. (“Takara Bio”), today announced the launch of the Takara Bio Certified Service Provider […]
Advancing discovery from lab to life through AI-driven insights, imaging, and end-to-end workflows WALTHAM, Mass. — Revvity, Inc. is showcasing its latest innovations in cancer research at the AACR Annual Meeting 2026, to be held in San Diego, April 17-22. The Company’s comprehensive suite of research use only (RUO) oncology solutions are designed to elevate preclinical and translational […]
Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems™, Bio-Techne Spatial™, and Bio-Techne Diagnostics™. The new brand structure reflects the scientific journey, connecting early discoveries to translational insight to clinical decision-making. The portfolio brands will debut at the AACR Annual Meeting 2026 and AAI’s IMMUNOLOGY 2026™. MINNEAPOLIS — […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting on April 17–22, 2026, in San Diego, California. At the meeting, Agilent will highlight advances designed to connect discovery research, translational science, and […]
Awards celebrate scientists making a difference through scientific mentorship, humanitarian service, environmental stewardship and artistic/creative spirit IPSWICH, MA – New England Biolabs (NEB®) today announced an invitation for scientists to submit entries for the 2026 Passion in Science Awards, recognizing those within the scientific community working to make a difference in the areas of scientific mentorship, humanitarian […]
OBERKOCHEN, Germany — Revolune, a new life science company focused on enabling clearer insights from complex biological systems, today announced its official launch. The company is dedicated to advancing spatial biology through streamlined multiplex immunofluorescence (mIF) reagents designed to deliver reliable, efficient, and scalable tissue analysis workflows for translational and biopharma research. Modern biomedical research […]
The Content Innovation Engine brings together Akoya’s spatial biology platform and Quanterix’s immunoassay infrastructure to systematically unlock cancer biology and accelerate the path toward clinical application BILLERICA, Mass. — Quanterix Corporation (Nasdaq: QTRX) today announced plans to debut its Content Innovation Engine at the American Association for Cancer Research (AACR) Annual Meeting 2026. Built on the integration […]
ArgusEye AB today announce the appointment of Sofia Håkansson Buch as its new Chief Executive Officer (CEO), marking an important step in the company’s next phase of growth. With a strong background in biopharma, Sofia will lead the company’s continued growth and commercialization of its real-time bioprocess monitoring platform. Sofia brings extensive experience from the […]
New Offering Integrates DOPPL’s Patient-Derived Intestinal Organoid Technology with InSphero’s Proven Standardized Screening Model Schlieren, Switzerland – InSphero AG, the global leader in 3D cell-based assays and organ-on-chip systems, today announced the commercial launch of the 3D InSight™ Drug-Induced Gastrointestinal Toxicity (DIGIT) platform, a standardized, high-throughput screening solution for early assessment of gastrointestinal liabilities in drug discovery. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
